Penn Pharma, a UK-based pharmaceutical manufacturer, has produced the first batch of coated tablets in its new contained manufacturing operation.
Subscribe to our email newsletter
Built for the clinical and commercial manufacture of tablets and capsules, the 15,000 ft² facility in South Wales will enable Penn Pharma to improve on its heritage and varied services.
Penn Pharma CEO Richard Yarwood said that the company has built a world-class facility for contained manufacturing and produced the first batch of coated tablets.
Penn Pharma chief operating officer Mark Dean-Netscher said, "A facility of this complex nature was a tight build in the timeframe, but we have demonstrated that when Penn Pharma commits to something, we always deliver."